ID29728A - Proses untuk pembuatan piridin-piridin tersubstitusi - Google Patents

Proses untuk pembuatan piridin-piridin tersubstitusi

Info

Publication number
ID29728A
ID29728A IDP20010276D ID20010276D ID29728A ID 29728 A ID29728 A ID 29728A ID P20010276 D IDP20010276 D ID P20010276D ID 20010276 D ID20010276 D ID 20010276D ID 29728 A ID29728 A ID 29728A
Authority
ID
Indonesia
Prior art keywords
piridins
making substituted
substituted
making
substituted piridins
Prior art date
Application number
IDP20010276D
Other languages
English (en)
Inventor
Robert Lee Dow
Steven Roy Schneider
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID29728A publication Critical patent/ID29728A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/188—Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IDP20010276D 2000-03-31 2001-03-30 Proses untuk pembuatan piridin-piridin tersubstitusi ID29728A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19377200P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
ID29728A true ID29728A (id) 2001-10-04

Family

ID=22714938

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20010276D ID29728A (id) 2000-03-31 2001-03-30 Proses untuk pembuatan piridin-piridin tersubstitusi

Country Status (25)

Country Link
US (4) US6518431B2 (id)
EP (1) EP1138685B1 (id)
JP (1) JP2001316393A (id)
KR (2) KR100435128B1 (id)
CN (1) CN1191235C (id)
AR (1) AR033812A1 (id)
AT (1) ATE267204T1 (id)
AU (1) AU782272B2 (id)
BR (1) BR0101280A (id)
CA (1) CA2342571A1 (id)
CZ (1) CZ20011194A3 (id)
DE (1) DE60103317T2 (id)
DK (1) DK1138685T3 (id)
ES (1) ES2217090T3 (id)
HU (1) HUP0101332A3 (id)
ID (1) ID29728A (id)
MX (1) MXPA01003383A (id)
PL (1) PL346805A1 (id)
PT (1) PT1138685E (id)
RU (1) RU2223956C2 (id)
SI (1) SI1138685T1 (id)
TR (1) TR200401359T4 (id)
TW (1) TW555761B (id)
YU (1) YU23301A (id)
ZA (1) ZA200102538B (id)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102037602B1 (ko) 2018-04-20 2019-10-28 사단법인 한국지능형교통체계협회 저상 버스용 고정 바를 갖춘 휠체어 잠금장치
KR20190122333A (ko) 2018-04-20 2019-10-30 사단법인 한국지능형교통체계협회 스터드 레일 피팅

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
WO1997046556A1 (en) * 1996-06-07 1997-12-11 Merck & Co., Inc. OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
US5792871A (en) 1996-07-22 1998-08-11 Merck & Co., Inc. Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide
ID22273A (id) * 1997-01-28 1999-09-23 Merck & Co Inc TIAZOL BENZENASULFONAMIDA SEBAGAI AGONIS β UNTUK PENGOBATAN DIABETES DAN OBESITAS
AU2571300A (en) * 1999-02-16 2000-09-04 Kaneka Corporation Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active beta3 agonist by the use of the same

Also Published As

Publication number Publication date
EP1138685A2 (en) 2001-10-04
ATE267204T1 (de) 2004-06-15
DK1138685T3 (da) 2004-08-09
ZA200102538B (en) 2002-09-30
HUP0101332A3 (en) 2004-07-28
US6670480B2 (en) 2003-12-30
HUP0101332A2 (en) 2002-10-28
ES2217090T3 (es) 2004-11-01
US6844441B2 (en) 2005-01-18
CA2342571A1 (en) 2001-09-30
DE60103317T2 (de) 2005-06-16
HK1038019A1 (en) 2002-03-01
RU2223956C2 (ru) 2004-02-20
TW555761B (en) 2003-10-01
EP1138685B1 (en) 2004-05-19
HU0101332D0 (en) 2001-06-28
US20050113578A1 (en) 2005-05-26
TR200401359T4 (tr) 2004-08-23
EP1138685A3 (en) 2003-04-02
KR100481603B1 (ko) 2005-04-08
PL346805A1 (en) 2001-10-08
PT1138685E (pt) 2004-08-31
SI1138685T1 (en) 2004-12-31
JP2001316393A (ja) 2001-11-13
KR20030072295A (ko) 2003-09-13
YU23301A (sh) 2003-04-30
CZ20011194A3 (cs) 2002-02-13
US20030114670A1 (en) 2003-06-19
DE60103317D1 (de) 2004-06-24
US20020077478A1 (en) 2002-06-20
MXPA01003383A (es) 2005-08-26
BR0101280A (pt) 2001-11-06
CN1320596A (zh) 2001-11-07
US6518431B2 (en) 2003-02-11
AU782272B2 (en) 2005-07-14
US20040133005A1 (en) 2004-07-08
KR100435128B1 (ko) 2004-06-09
AR033812A1 (es) 2004-01-07
AU3334801A (en) 2001-12-13
CN1191235C (zh) 2005-03-02
KR20010095192A (ko) 2001-11-03

Similar Documents

Publication Publication Date Title
ID26007A (id) Proses karbonilasi
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DE60117286D1 (de) Prozesssteuerung
ID24790A (id) Proses untuk memfraksionasi dibutena
ID27308A (id) Proses aksidasi
ID28724A (id) Proses untuk memproduksi sikloalkanon
DE60137595D1 (de) Bilderzeugungsverfahren
ID26102A (id) Proses pembuatan senyawa-senyawa stilbena
ID26441A (id) Proses untuk memproduksi ftalat anhidrida
ID23316A (id) Proses karbonilasi
ID30168A (id) Proses pembuatan bisfenol a
ID29673A (id) Proses untuk pembuatan turunan-turunan resorsinol
NO20024893L (no) Fremgangsmater for ansamitocin-produksjon
ID30503A (id) Proses yang diperbaiki untuk pembuatan heksametilenadiamina
DE10196082T1 (de) FLIP-CHIP-Montageverfahren
FI20001612L (fi) Menetelmä kuitulevyjen valmistamiseksi
ID29787A (id) Proses untuk memproduksi cairan kaya-metana
ID29177A (id) Proses pembuatan urea
ID27830A (id) Proses pembuatan neotame
ID26278A (id) Proses pembuatan sertralina dari kiral tetralon
IS6716A (is) Aðferðir við að framleiða sílostasól
DE60130137D1 (de) Kristallisationsverfahren
ID28625A (id) Proses untuk modifikasi pektin secara enzimatik
DE60130426D1 (de) Aluminiumoxid-Leuchtstoff- Herstellungsverfahren
ID27404A (id) Proses asilasi